Kleo Pharmaceuticals Inc.

The company discovers small molecules that induce desired protein-protein interactions using an arsenal of screening technologies

Plus Arvinas hires Northcott as CCO, Manion joins Aclaris and updates from AnHeart, Gracell, Find and more 

Plus: Nuyten joining Nektar and updates from Janux, UKI2S, Arena and ArsenalBio 

Cell therapy company Arsenal Biosciences Inc. hired Tim Sirichoke as chief technical operations officer and John Schroer as CFO. Most recently Sirichoke was VP of individualized neo-antigen specific

Cullinan upsizes IPO for $250M raise Cullinan Management Inc. (NASDAQ:CGEM) raised $249.9 million in an IPO via the sale of 11.9 million shares at $21. The company had planned to sell 10 million

How Kleo's small molecules mimic or enhance antibodies for immuno-oncology